Learn how seamless dedicated program management, through one point of contact, can help you to avoid delays, errors and inconsistent feedback.
When working with different CDMs and CROs, pharmaceutical companies face many difficult challenges. These include lack of communication and alignment between all parties, which can result in delays, errors and inconsistent feedback, from clinic to formulation optimization. These can be addressed with seamless dedicated program management through one point of contact.
We invite you to our SGS LinkedIn Live: How to streamline the drug development pathway from preclinic to FIH/POC, in which Dr. Jelle Klein, Medical Director, SGS Clinical Research – CPU and Mike Frodsham, Chief Technical Officer, CDMO of SGS’s Quay Pharma will explain the challenges the industry is facing and how SGS PACE will support pharma and biopharma companies in their drug development journey, allowing them to achieve increased flexibility, efficiency and speed.
Discover how SGS PACE brings together bioanalysis, formulation, manufacturing and clinical research services through one partner and one dedicated point of contact. Our experts will discuss how building a bespoke pathway, from pre-clinical through FIH/POC, with one provider will enable you to overcome the current challenges of working with different CDMOs and CROs. They will highlight how SGS PACE’s flexible project delivery will provide you with the ultimate program to deliver clinical results effectively and efficiently.
Join the session as they guide you through an expert-directed roadmap to clinic, through one program manager, showing you how you can save valuable time.
- Discover how SGS PACE brings together bioanalysis, formulation and manufacturing and clinical research services through one partner and one dedicated point of contact
- The challenges which the health science industry is facing and how they can be addressed with seamless dedicated program management through one point of contact
- How working with one organization helps the customer and what kind of timelines can be expected
- How SGS PACE brings together world-leading clinical drug development through one organization and one point of contact
Target Audience: The webinar is aimed at all pharmaceutical and biopharmaceutical companies.
For further information, please contact:
Global Marketing Manager
t: +44 (0) 7874 867837